EPIRUS Biopharmaceuticals, Inc. announced that on June 30, 2016, each of Michael Wyand, the company's President and Chief Operating Officer, and Thomas Shea the company's Senior Vice President, Chief Financial Officer and Treasurer, were terminated from their respective positions with the company in connection with the wind-down of the company's Operations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 26 | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- EPRSQ Stock
- News EPIRUS Biopharmaceuticals, Inc.
- EPIRUS Biopharmaceuticals, Inc. Announces Executive Termination